Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imaging.

類似資料

• MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.
  著者:: Bo Ram Kim, 等
  出版事項: (2016-01-01)
• Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
  著者:: Tae Hoon Roh, 等
  出版事項: (2020-07-01)
• Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods.
  著者:: Seung Chai Jung, 等
  出版事項: (2013-01-01)
• Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.
  著者:: Sherriff, J, 等
  出版事項: (2013)
• Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results.
  著者:: Takahiro Oike, 等
  出版事項: (2013-01-01)